Literature DB >> 7931344

Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity.

J G Sheng1, F A Boop, R E Mrak, W S Griffin.   

Abstract

Levels of immunoreactive beta-amyloid precursor protein and interleukin-1 alpha were found to be elevated in surgically resected human temporal lobe tissue from patients with intractable epilepsy compared with postmortem tissue from neurologically unaffected patients (controls). In tissue from epileptics, the levels of the 135-kDa beta-amyloid precursor protein isoform were elevated to fourfold (p < 0.05) those of controls and those of the 130-kDa isoform to threefold (p < 0.05), whereas those of the 120-kDa isoform (p > 0.05) were not different from control values. beta-Amyloid precursor protein-immunoreactive neurons were 16 times more numerous, and their cytoplasm and proximal processes were more intensely immunoreactive in tissue sections from epileptics than controls (133 +/- 12 vs. 8 +/- 3/mm2; p < 0.001). However, neither beta-amyloid precursor protein-immunoreactive dystrophic neurites nor beta-amyloid deposits were found in this tissue. Interleukin-1 alpha-immunoreactive cells (microglia) were three times more numerous in epileptics than in controls (80 +/- 8 vs. 25 +/- 5/mm2; p < 0.001), and these cells were often found adjacent to beta-amyloid precursor protein-immunoreactive neuronal cell bodies. Our findings, together with functions established in vitro for interleukin-1, suggest that increased expression of this protein contributes to the increased levels of beta-amyloid precursor protein in epileptics, thus indicating a potential role for both of these proteins in the neuronal dysfunctions, e.g., hyperexcitability, characteristic of epilepsy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931344      PMCID: PMC3833617          DOI: 10.1046/j.1471-4159.1994.63051872.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  46 in total

1.  Cytokine regulation of neuronal survival.

Authors:  D E Brenneman; M Schultzberg; T Bartfai; I Gozes
Journal:  J Neurochem       Date:  1992-02       Impact factor: 5.372

2.  Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity.

Authors:  N Kitaguchi; Y Takahashi; Y Tokushima; S Shiojiri; H Ito
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

3.  On the origin of Alzheimer's disease: a hypothesis.

Authors:  G W Roberts; M Nash; P G Ince; M C Royston; S M Gentleman
Journal:  Neuroreport       Date:  1993-01       Impact factor: 1.837

4.  Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease.

Authors:  E Cochran; B Bacci; Y Chen; A Patton; P Gambetti; L Autilio-Gambetti
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

5.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

Authors:  B Rumble; R Retallack; C Hilbich; G Simms; G Multhaup; R Martins; A Hockey; P Montgomery; K Beyreuther; C L Masters
Journal:  N Engl J Med       Date:  1989-06-01       Impact factor: 91.245

6.  Tissue-specific expression of three types of beta-protein precursor mRNA: enhancement of protease inhibitor-harboring types in Alzheimer's disease brain.

Authors:  S Tanaka; S Shiojiri; Y Takahashi; N Kitaguchi; H Ito; M Kameyama; J Kimura; S Nakamura; K Ueda
Journal:  Biochem Biophys Res Commun       Date:  1989-12-29       Impact factor: 3.575

7.  Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor.

Authors:  J D Buxbaum; M Oishi; H I Chen; R Pinkas-Kramarski; E A Jaffe; S E Gandy; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

8.  Alterations in striatal glial fibrillary acidic protein expression in response to 6-hydroxydopamine-induced denervation.

Authors:  J G Sheng; S Shirabe; N Nishiyama; J P Schwartz
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

9.  Interleukin-1 is an astroglial growth factor in the developing brain.

Authors:  D Giulian; D G Young; J Woodward; D C Brown; L B Lachman
Journal:  J Neurosci       Date:  1988-02       Impact factor: 6.167

10.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Authors:  W S Griffin; L C Stanley; C Ling; L White; V MacLeod; L J Perrot; C L White; C Araoz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

View more
  56 in total

1.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

2.  BACE1 elevation is associated with aberrant limbic axonal sprouting in epileptic CD1 mice.

Authors:  Xiao-Xin Yan; Yan Cai; Xue-Mei Zhang; Xue-Gang Luo; Huaibin Cai; Gregory M Rose; Peter R Patrylo
Journal:  Exp Neurol       Date:  2012-01-11       Impact factor: 5.330

3.  Brain Inflammation and Seizures.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2004-03       Impact factor: 7.500

Review 4.  Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy.

Authors:  Bruce Hermann; Michael Seidenberg; Mark Sager; Cynthia Carlsson; Barry Gidal; Raj Sheth; Paul Rutecki; Sanjay Asthana
Journal:  Epilepsia       Date:  2007-11-21       Impact factor: 5.864

Review 5.  The multifaceted profile of activated microglia.

Authors:  Marina A Lynch
Journal:  Mol Neurobiol       Date:  2009-07-23       Impact factor: 5.590

6.  Leukocyte-endothelial adhesion mechanisms in epilepsy: cheers and jeers.

Authors:  Annamaria Vezzani; Damir Janigro
Journal:  Epilepsy Curr       Date:  2009 Jul-Aug       Impact factor: 7.500

7.  Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures.

Authors:  Mattia Maroso; Silvia Balosso; Teresa Ravizza; Jaron Liu; Eleonora Aronica; Anand M Iyer; Carlo Rossetti; Monica Molteni; Maura Casalgrandi; Angelo A Manfredi; Marco E Bianchi; Annamaria Vezzani
Journal:  Nat Med       Date:  2010-03-28       Impact factor: 53.440

8.  Gene expression of glutamate metabolizing enzymes in the hippocampal formation in human temporal lobe epilepsy.

Authors:  Tore Eid; Tih-Shih W Lee; Yue Wang; Edgar Perez; Edgar Peréz; Jana Drummond; Fredrik Lauritzen; Linda H Bergersen; James H Meador-Woodruff; Dennis D Spencer; Nihal C de Lanerolle; Robert E McCullumsmith
Journal:  Epilepsia       Date:  2012-11-13       Impact factor: 5.864

Review 9.  Glial cell dysregulation: a new perspective on Alzheimer disease.

Authors:  Rommy von Bernhardi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

10.  Down-regulation of APLP1 mRNA expression in hippocampus of pilocarpine-induced epileptic rats.

Authors:  Cheng Wang; Zi-Li You; Ding-Ding Zhang
Journal:  Neurosci Bull       Date:  2009-06       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.